Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy
Angiogenesis, the sprouting of new blood vessels from existing vessels, is one of six known
mechanisms employed by solid tumors to recruit blood vessels necessary for their initiation …
mechanisms employed by solid tumors to recruit blood vessels necessary for their initiation …
The role of the CXCL12/CXCR4/CXCR7 chemokine axis in cancer
Chemokines are a family of small, secreted cytokines which regulate a variety of cell
functions. The CXC motif chemokine ligand 12 (CXCL12) binds to CXC chemokine receptor …
functions. The CXC motif chemokine ligand 12 (CXCL12) binds to CXC chemokine receptor …
The challenge of drug resistance in cancer treatment: a current overview
M Nikolaou, A Pavlopoulou, AG Georgakilas… - Clinical & Experimental …, 2018 - Springer
It is generally accepted that recent advances in anticancer agents have contributed
significantly to the improvement of both the disease-free survival and quality of life in cancer …
significantly to the improvement of both the disease-free survival and quality of life in cancer …
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
GS Karagiannis, JM Pastoriza, Y Wang… - Science translational …, 2017 - science.org
Breast cancer cells disseminate through TIE2/MENACalc/MENAINV-dependent cancer cell
intravasation sites, called tumor microenvironment of metastasis (TMEM), which are …
intravasation sites, called tumor microenvironment of metastasis (TMEM), which are …
[HTML][HTML] Integrins in cancer: Emerging mechanisms and therapeutic opportunities
F Liu, Q Wu, Z Dong, K Liu - Pharmacology & therapeutics, 2023 - Elsevier
Integrins are vital surface adhesion receptors that mediate interactions between the
extracellular matrix (ECM) and cells and are essential for cell migration and the …
extracellular matrix (ECM) and cells and are essential for cell migration and the …
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
SS McAllister, RA Weinberg - Nature cell biology, 2014 - nature.com
Recent pre-clinical and clinical research has provided evidence that cancer progression is
driven not only by a tumour's underlying genetic alterations and paracrine interactions within …
driven not only by a tumour's underlying genetic alterations and paracrine interactions within …
Microenvironmental regulation of therapeutic response in cancer
The tumor microenvironment (TME) not only plays a pivotal role during cancer progression
and metastasis but also has profound effects on therapeutic efficacy. In the case of …
and metastasis but also has profound effects on therapeutic efficacy. In the case of …
MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
H Wu, B Liu, Z Chen, G Li, Z Zhang - Cell death & disease, 2020 - nature.com
Chemotherapy is the first-tier treatment regime for gastric cancer (GC) patients at advance
stages. Mesenchymal stem cell (MSC) cam affect drug-resistance of GC cells in tumor …
stages. Mesenchymal stem cell (MSC) cam affect drug-resistance of GC cells in tumor …
Perivascular M2 macrophages stimulate tumor relapse after chemotherapy
R Hughes, BZ Qian, C Rowan, M Muthana… - Cancer research, 2015 - AACR
Tumor relapse after chemotherapy-induced regression is a major clinical problem, because
it often involves inoperable metastatic disease. Tumor-associated macrophages (TAM) are …
it often involves inoperable metastatic disease. Tumor-associated macrophages (TAM) are …
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
NS Vasudev, AR Reynolds - Angiogenesis, 2014 - Springer
Tumours require a vascular supply to grow and can achieve this via the expression of pro-
angiogenic growth factors, including members of the vascular endothelial growth factor …
angiogenic growth factors, including members of the vascular endothelial growth factor …